Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
50 participants
INTERVENTIONAL
2021-08-31
2022-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Acceleromyography (AMG) and Mechanomyography (MMG) for Establishing Potency of Neuromuscular Blocking Agents
NCT00660413
Comparison of Two Neuromuscular Transmission Monitors Based on Acceleromyography: TOF-Watch SX® and TOFScan®
NCT02880787
A Device to Determine Return of Sensation From Spinal Block
NCT04553913
Clinical Application and Validation of Innovative Tourniquet
NCT05605990
TRK-3 Performance of Pachymetry
NCT06250868
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
adductor pollicis AP
Measurement site: M.adductor pollicis of both arms.
acceleromyography
Simultaneous measurement of the time course of a neuromuscular block with 2 acceleromyographs
Corrugator supercilii CS
Measurement site: M. corrugator supercilii at both sides
acceleromyography
Simultaneous measurement of the time course of a neuromuscular block with 2 acceleromyographs
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
acceleromyography
Simultaneous measurement of the time course of a neuromuscular block with 2 acceleromyographs
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Risk of pulmonary aspiration
* acute infection
* pregnancy
* renal or hepatic insufficiency
* neuromuscular disease
* chronic intake of drugs influencing neuromuscular block
18 Years
65 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kreiskrankenhaus Dormagen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Stefan Soltesz
Prof. Dr. Stefan Soltesz
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
KKH Dormagen
Dormagen, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TOF 3D
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.